EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 104 filers reported holding EVOFEM BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $517,000 | +1.2% | 1,521,357 | +11.7% | 0.00% | – |
| Q4 2021 | $511,000 | -48.4% | 1,362,128 | +1.5% | 0.00% | – |
| Q3 2021 | $991,000 | -24.4% | 1,342,497 | +15.7% | 0.00% | – |
| Q2 2021 | $1,311,000 | -43.3% | 1,160,784 | -12.2% | 0.00% | – |
| Q1 2021 | $2,313,000 | -22.6% | 1,321,845 | +6.5% | 0.00% | -100.0% |
| Q4 2020 | $2,990,000 | +19.5% | 1,240,869 | +17.0% | 0.00% | – |
| Q3 2020 | $2,503,000 | +65.0% | 1,060,876 | +97.8% | 0.00% | – |
| Q2 2020 | $1,517,000 | +7.6% | 536,314 | +102.2% | 0.00% | – |
| Q1 2020 | $1,410,000 | -56.2% | 265,176 | -49.1% | 0.00% | – |
| Q4 2019 | $3,216,000 | +125.8% | 521,250 | +84.5% | 0.00% | – |
| Q3 2019 | $1,424,000 | -24.1% | 282,551 | +0.1% | 0.00% | – |
| Q2 2019 | $1,875,000 | +621.2% | 282,395 | +279.3% | 0.00% | – |
| Q1 2019 | $260,000 | -57.8% | 74,451 | -49.5% | 0.00% | – |
| Q4 2018 | $616,000 | +346.4% | 147,300 | +330.4% | 0.00% | – |
| Q3 2018 | $138,000 | – | 34,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Wealth Management Partners | 545,413 | $954,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,655,400 | $4,647,000 | 0.29% |
| Maven Securities LTD | 2,750,000 | $4,826,000 | 0.22% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 150,000 | $263,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 265,286 | $464,000 | 0.08% |
| GREAT LAKES ADVISORS, LLC | 1,697,052 | $2,970,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 2,335,305 | $4,087,000 | 0.04% |
| Virtu Financial LLC | 174,447 | $305,000 | 0.02% |
| Game Plan Financial Advisors, LLC | 18,500 | $33,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $4,720,000 | 0.02% |